Comparison

Falnidamol European Partner

Item no. TMO-TQ0271-2mg
Manufacturer TargetMol
CASRN 196612-93-8
Amount 2 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 200 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Smiles CN1CCC(CC1)Nc1ncc2ncnc(Nc3ccc(F)c(Cl)c3)c2n1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias BIBX 1382
Shipping Condition Cool pack
Available
Manufacturer - Targets
EGFR
Storage Conditions
-20
Molecular Weight
387.84
Description
Falnidamol (BIBX 1382) is an orally active, selective EGFR tyrosine kinase inhibitor with an IC50 of 3 nM. It displays >1000-fold lower potency against ErbB2 (IC50=3.4 μM) and other related tyrosine kinases (IC50>10 μM). Falnidamol is a pyrimido-pyrimidine compound and exhibits anti-cancer activity.
Pathways
Tyrosine Kinase/Adaptors|||Angiogenesis|||JAK/STAT signaling

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 2 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close